Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MAPK/ERK pathway (Ras-Raf-MEK-ERK pathway) is a central signal transduction cascade in eukaryotic cells, critical for transmitting extracellular growth signals to the nucleus via a sequence of phosphorylation events. It begins with activation of a cell surface receptor (often a receptor tyrosine kinase), leading to recruitment and activation of small GTPases such as Ras. Active Ras then stimulates a cascade of serine/threonine kinases — Raf (MAP3K) ➔ MEK1/2 (MAP2K) ➔ ERK1/2 (MAPK). Activated ERK translocates to the nucleus to regulate gene expression controlling cell proliferation, differentiation, and survival. Dysregulation of this pathway, particularly through oncogenic mutations in Ras or BRAF, is implicated in numerous cancers and developmental syndromes.
Inhibit kinase activity (e.g., BRAF or MEK inhibitors prevent downstream signaling) Block mutant Ras protein function (e.g., direct KRAS G12C inhibition) Modulate pathway activation at the receptor or GTPase level
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase signaling pathway (Ras-Raf-MEK-ERK pathway) (MAPK pathway (also called ERK pathway or Ras-Raf-MEK-ERK pathway)).